CANCER GENETICS

CGIX NASDAQ
0.1749
-0.0002
-0.11%
Closed 16:37 05/23 EDT
Open
0.1729
Prev Close
0.1751
High
0.1865
Low
0.1530
Volume
3.80M
Avg Vol (3M)
1.61M
52 Week High
1.300
52 Week Low
0.1518
% Turnover
6.58%
Market Cap
10.11M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Company Profile

Cancer Genetics, Inc. is a United States-based company, which is engaged in the field of personalized medicine. The Company offers diagnostic products and services that enable precision medicine in the field of oncology through molecular markers and diagnostics. The Company offers a range of laboratory services that provide genomic and biomarker information. Its Select One Clinical Trials program provides a range of integrated and dynamic clinical trial services for both oncology and non-oncology genetic testing for Phase I-III trials along with ancillary services, including bioinformatics, biorepository and trials logistic support. The Company is developing a global footprint with locations in the United States, India and China. It also offers a portfolio of genotyping services, with access to over 400 validated genotyping assays, including Phase I and Phase II drug metabolizing enzymes, transporters, and receptors, and over 30 validated gene expression assays.
MORE >

Recently

Name
Price
%Change